President Trump and Healthcare (And Pharma) Sector: What's Next?
Now that the initial shock period is over, we return to finding out how President Trump could affect the U.S. (and with it the global) healthcare...
378 Views
SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
342 Views
Winds Across the Pacific: What the US Election Will Bring to Asia
The bitter divisiveness of the campaign, between Democrat Hillary Clinton and her Republican rival Donald Trump, reflects the deep disaffection of...
234 Views
Recap of Key Events in the U.S. Biotechnology and Pharmaceutical Sector: Mid-Week Update
Galapagos NV (GLPG NA)Â seems to have got some investor attention after the successful results of Celgene Corp (CELG US)Â anti-inflammatory product...
503 Views
Monsanto/Bayer Merger to Face Opposition in Africa
Bayer’s $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South...
214 Views